Karyopharm Therapeutics, Inc. (KPTI)
5.89
+0.07
(+1.20%)
USD |
NASDAQ |
Apr 02, 16:00
5.89
0.00 (0.00%)
After-Hours: 20:00
Karyopharm Therapeutics Market Cap : 109.53M for April 2, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Gilead Sciences, Inc. | 172.67B |
| Catalyst Pharmaceuticals, Inc. | 2.997B |
| Alnylam Pharmaceuticals, Inc. | 40.99B |
| Agios Pharmaceuticals, Inc. | 2.124B |
| Ocugen, Inc. | 585.30M |
Market Cap Related Metrics
| PS Ratio | 0.4402 |
| PEG Ratio | -0.0013 |
| Price | 5.89 |
| Earnings Yield | -282.2% |
| PEGY Ratio | -0.0013 |